Basic Information

Reference Number

0000287242

Issuing Organization

University Of Calgary

Solicitation Type

RFQ - Request for Quote (Formal)

Solicitation Number

2025RFQ0001

Title

GemCell Human Serum

Source ID

PU.AC.Alta..1083035.C108344

Agreement Types

Canadian Free Trade Agreement (CFTA)

New West Partnership Trade Agreement (NWPTA)

Details

Location

Canada, Alberta, Calgary

Description

The University of Calgary (UCalgary) is looking for a supplier to provide the GemCell™ Plus Xeno-free Human Serum (AB Serotype) and GemCell™ U.S. Origin Human Serum (AB Serotype). The GemCell™ Human Serum is a critical component in the validated processes supporting UCalgary Riddell Centre for Cancer Immunotherapy’s CAR T cell manufacturing program and Clinical Trial Application (CTA) to Health Canada. This specific serum lot has been used extensively in the lab for validation work, and its characteristics ensure it meets the stringent requirements for clinical-grade applications. Regulatory guidelines mandate the continued use of the same lot of serum during the clinical trial to maintain consistency and alignment with the data submitted in the CTA. Any deviation, such as switching to a different lot or product, would require revalidation to confirm comparability, resulting in significant delays, additional costs, and potential risks to the integrity of the clinical trial.

Dates

Publication

2025/02/10 04:00:59 PM MST

Bid Intent

Not Available

Question Acceptance Deadline

2025/02/14 04:00:00 PM MST

Questions are submitted online

Yes

Closing DateA - Latest Amendment

2025/02/24 04:00:00 PM MST

Contact Information

Ling Li

403-220-5748

lingrong.li@ucalgary.ca

Bid Submission Process

Bid Submission Type

Electronic Bid Submission

Pricing

In attached document

Bid Documents List

Item Name	Description	Mandatory	Limited to 1 file
Bid Documents	Documents defining the proposal	Yes	No
No entries

© MERX - All rights reserved. No part of the information on this Web Site may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of MERX and the Minister of the participating government department (if applicable). MERX, the Minister nor the Contracting Authority will assume responsibility or liability for the accuracy of the information contained in the publication.